An important piece of information that we lack is an accurate picture of the current spread of COVID-19. One way to get that information is to deploy widespread and high-quality serologic antibody testing.
The world at large is having to abide by social distancing orders amidst COVID-19, which is something that individuals with CF have been experiencing to some degree for much of their lives to protect their health.
Whole genome sequencing (WGS), the process of determining the complete nucleotide or DNA/RNA sequence of a genome at one time, has made headlines recently for its potential to transform infectious disease management, particularly related to SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
Laboratories around the world have paused regular work to pursue treatment for COVID-19. While there are still no evidence-based treatments available, scientists are evaluating a variety of options beyond supportive care.